For the year ending 2025-12-31, NVCR has $804,326K in assets. $463,860K in debts. $93,548K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 93,548 | |||
| Short-term investments | 354,126 | |||
| Restricted cash | 9,842 | |||
| Trade receivables, net | 89,435 | |||
| Receivables and prepaid expenses | 58,669 | |||
| Inventories | 41,111 | |||
| Total current assets | 646,731 | |||
| Property and equipment, net | 77,606 | |||
| Field equipment, net | 22,066 | |||
| Right-of-use assets | 47,327 | |||
| Other long-term assets | 10,596 | |||
| Total long-term assets | 157,595 | |||
| Total assets | 804,326 | |||
| Convertible note | 0 | |||
| Trade payables | 122,231 | |||
| Other payables, lease liabilities and accrued expenses | 100,997 | |||
| Total current liabilities | 223,228 | |||
| Senior secured credit facility, net | 195,047 | |||
| Long term leases | 41,647 | |||
| Employee benefit liabilities | 3,938 | |||
| Total long-term liabilities | 240,632 | |||
| Total liabilities | 463,860 | |||
| Ordinary shares - no par value, unlimited shares authorized issued and outstanding 112,492,667 shares and 108,516,819 shares at december31, 2025 and december31, 2024 respectively | 0 | |||
| Additional paid-in capital | 1,634,264 | |||
| Accumulated other comprehensive income (loss) | -3,441 | |||
| Retained earnings (accumulated deficit) | -1,290,357 | |||
| Total shareholders equity | 340,466 | |||
| Total liabilities and shareholders equity | 804,326 | |||
NovoCure Ltd (NVCR)
NovoCure Ltd (NVCR)